Biochemical and functional characterization of the Ebola virus VP24 protein: Implications for a role in virus assembly and budding

被引:89
作者
Han, ZY
Boshra, H
Sunyer, JO
Zwiers, SH
Paragas, J
Harty, RN
机构
[1] Univ Penn, Sch Vet Med, Dept Pathobiol, Lab 412, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Vet Med, Dept Pathobiol, Lab 413, Philadelphia, PA 19104 USA
[3] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA
关键词
D O I
10.1128/JVI.77.3.1793-1800.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The VP24 protein of Ebola virus is believed to be a secondary matrix protein and minor component of virions. In contrast, the VP40 protein of Ebola virus is the primary matrix protein and the most abundant virion component. The structure and function of VP40 have been well characterized; however, virtually nothing is known regarding the structure and function of VP24. Wild-type and mutant forms of VP24 were expressed in mammalian cells to gain a better understanding of the biochemical and functional nature of this viral protein. Results from these experiments demonstrated that (i) VP24 localizes to the plasma membrane and perinuclear region in both transfected and Ebola virus-infected cells, (ii) VP24 associates strongly with lipid membranes, (iii)VP24 does not contain N-linked sugars when expressed alone in mammalian cells, (iv) VP24 can oligomerize when expressed alone in mammalian cells, (v) progressive deletions at the N terminus of VP24 resulted in a decrease in oligomer formation and a concomitant increase in the formation of high-molecular-weight aggregates, and (vi) VP24 was present in trypsin-resistant virus like particles released into the media covering VP24-transfected cells. These data indicate that VP24 possesses structural features commonly associated with viral matrix proteins and that VP24 may have a role in virus assembly and budding.
引用
收藏
页码:1793 / 1800
页数:8
相关论文
共 32 条
[1]   Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses [J].
Bavari, S ;
Bosio, CM ;
Wiegand, E ;
Ruthel, G ;
Will, AB ;
Geisbert, TW ;
Hevey, M ;
Schmaljohn, C ;
Schmaljohn, A ;
Aman, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :593-602
[2]  
BORDIER C, 1981, J BIOL CHEM, V256, P1604
[3]   Experimental therapy of filovirus infections [J].
Bray, M ;
Paragas, J .
ANTIVIRAL RESEARCH, 2002, 54 (01) :1-17
[4]   Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses [J].
Chan, SY ;
Speck, RF ;
Ma, MC ;
Goldsmith, MA .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4933-4937
[5]   Ebola haemorrhagic fever - a review [J].
Colebunders, R ;
Borchert, N .
JOURNAL OF INFECTION, 2000, 40 (01) :16-20
[6]   Crystallization and preliminary X-ray analysis of the matrix protein from Ebola virus [J].
Dessen, A ;
Forest, E ;
Volchkov, V ;
Dolnik, O ;
Klenk, HD ;
Weissenhorn, W .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 :758-760
[7]   Crystal structure of the matrix protein VP40 from Ebola virus [J].
Dessen, A ;
Volchkov, V ;
Dolnik, O ;
Klenk, HD ;
Weissenhorn, W .
EMBO JOURNAL, 2000, 19 (16) :4228-4236
[8]   DESCRIPTIVE ANALYSIS OF EBOLA VIRUS PROTEINS [J].
ELLIOTT, LH ;
KILEY, MP ;
MCCORMICK, JB .
VIROLOGY, 1985, 147 (01) :169-176
[9]  
Feldmann H, 1999, ARCH VIROL, P159
[10]  
Fukuda M, 2000, J BIOL CHEM, V275, P28180